InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Cover Story

  • Roundtable: The second medical use challenge – full transcript

    Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London

Features

  • Trends to watch at the ITC after busy 2016 for IP investigations

    Highlights at the International Trade Commission in 2016 included the most Section 337 investigations since 2011, the first live hearing for a decade and the first antitrust claim for 25 years. Michael Loney asks ITC practitioners what trends they expect in 2017

  • A quiet year from the EU’s courts in design cases

    While 2016 was a quiet year for design decisions in the Court of Justice, 2017 looks to be a cracker year of important cases. In the first of two articles, David Stone looks back at the year that was. Next month, he looks forward to some of the key decisions expected in 2017

  • Avoid the tax shock in licensing agreements

    Christopher M Neumeyer reviews the lessons to be learned from two recent cases where Taiwan companies were ordered to pay taxes on licensing fees paid to a foreign licensor

  • Keeping IP strategy alive

    Nick McDonald looks at the characteristics of an effective IP strategy and the dangers of failing to keep it alive in a business

  • This year’s premier patent firms

    In this, the second part of this year’s IP Stars research, we rank the top firms in 80 jurisdictions for patent work

  • Africa steps up fight against counterfeits

    Africa is highly attractive to counterfeiters. But, explains Chris Walters, several governments in the continent have recently taken action to tackle the problem

  • Are you 3DP ready?

    3D printing is already causing disruption in some industries. Stella Wong considers how to develop a 3DP IP strategy, with a particular focus on the medical industry

Survey

Diary

  • Utynam’s Heirs

    Inspired by Valentine’s Day last month, Managing IP invited our Twitter followers to compose IP-related love poems, and received dozens of responses, from the beautiful to the bitter. Utynam has picked his favourites to share with you

Country Updates

profile

Managing IP

ManagingIP

ManagingIP profile

ICYMI: Our report on this week's #SCOTUS ruling in Star Athletica v Varsity Brands https://t.co/Rf3TWplNUrhttps://t.co/TrZ5YcvKQr

Mar 24 2017 01:35 ·  reply ·  retweet ·  favourite
ManagingIP profile

@Oblon_IP @PatentPostGrant Congratulations Scott! #mipawards

Mar 24 2017 01:13 ·  reply ·  retweet ·  favourite
ManagingIP profile

@KellyIPllp Well done to all at the firm!

Mar 24 2017 02:16 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements